Literature DB >> 10735184

"Difficult to treat infections" pharmacokinetic and pharmacodynamic factors--a review.

J M Schierholz1, J Beuth, G Pulverer.   

Abstract

"Difficult to cure infections" are characterized by poor penetration of antibiotics into infected vegetations, altered metabolic state of bacteria within the vegetation, absence of adequate host defense/cellular response. These infections typically include endocarditis, urinary tract infections (infected urinary tract stones), abscesses, infected fibrin clots (septic thromboemboli, haematomas, catheter-related infections) and foreign body infections. Four main aspects are discussed for the influence on human therapy: 1. the kinetics of antibiotic diffusion into vegetations 2. the specificity of some pharmacodynamic aspects and pharmacokinetic regimes 3. fibrin as one of the main constituents associated with infectious processes and 4. synergistical activities of antibiotic combinations on bacterial vegetations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735184

Source DB:  PubMed          Journal:  Acta Microbiol Immunol Hung        ISSN: 1217-8950            Impact factor:   2.048


  3 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Current clinical use of intravenous fosfomycin in ICU patients in two European countries.

Authors:  C Putensen; B Ellger; S G Sakka; A Weyland; K Schmidt; M Zoller; N Weiler; D Kindgen-Milles; U Jaschinski; J Weile; S Lindau; M Kieninger; A Faltlhauser; N Jung; P Teschendorf; M Adamzik; M Gründling; T Wahlers; H Gerlach; F-A Litty
Journal:  Infection       Date:  2019-06-12       Impact factor: 3.553

3.  A Spiral in the Heart: Mitral Valve Endocarditis with Unusual Vegetation Shape Potentially Affecting Effectiveness of Antibiotic Therapy.

Authors:  Veronica Fibbi; Piercarlo Ballo; Alessandro Abbondanti; Marco Nannini; Antonio Fazi
Journal:  Case Rep Cardiol       Date:  2015-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.